In a developmental toxicity study (MRID number if available) [Chemical name (% a.i.)] was administered to [(# of females) strain, species]/dose in [diet, water, by capsule, by gavage] at dose levels of 0, x, x, or x mg/kg bw/day from days [#] through [#] of gestation.
[Describe maternal toxicity briefly. If none, state that there were no treatment-related effects in mortality, clinical signs, body weight, food consumption, or cesarean parameters]. The maternal LOAEL is mg/kg bw/day, based on [endpoint]. The maternal NOAEL is mg/kg bw/day. Describe effects at doses >LOAEL.
[Describe developmental toxicity briefly. If none, state that there were no treatment-related effects in developmental parameters]. The developmental LOAEL is mg/kg bw/day, based on [endpoint]. The developmental NOAEL is mg/kg bw/day. Describe effects at doses >LOAEL.
The developmental toxicity study in the rat is classified [acceptable, unacceptable(why); note if it is a range-finding study] and satisfies (does not satisfy) the guideline requirement for a developmental toxicity study (OPPTS 870.3700; OECD 414) in [species]. [If it does not satisfy the requirement, concisely list only major deficiencies or refer to deficiency section.]